Clinical Trials Browser

INDUSTRY × Glioma × Afatinib × Clear all

NCT00727506 2017-08-15

BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma

Phase 2 Completed

151 enrolled 42 charts

Glioma